Editorial Board

Editor-in-Chief

Jun Wang, M.D., Ph.D., Peking University People's Hospital, Beijing, China 

Professor Jun Wang, Academician of Chinese Academy of Engineering, President of Peking University People’s Hospital, Beijing, China. Professor Jun Wang is the chief of Department of Thoracic Surgery, Peking University People’s Hospital and Chief of Minimal Invasive Thoracic Center, Peking University People’s Hospital. He is also the president of Lung Cancer Committee of China Anti-Cancer Association, the Chair of Thoracic Committee of Chinese Research Hospital Association. He has published over 400 articles on peer reviewed journals, e.g. Am J Respir Crit Care Med, Sci Adv, J Thorac Oncol, Eur Respir J, Autophagy and Clin Cancer Res. As the founder of video-assisted thoracic surgery and minimally invasive thoracic surgery in China, his research interests include surgical treatment and molecular mechanism of lung cancer esophageal cancer and mediastinal tumor.


Honorary Editor-in-Chief

Dayi Hu, Professor, Peking University People's Hospital, Beijing, China 

Professor Dayi Hu is a national and Beijing municipal expert with outstanding contributions and an academician of the International Eurasian Academy of Sciences. His current roles include being the chairman of the Chinese Association on Tobacco Control, chairman of the Cardiovascular Disease Prevention and Rehabilitation Committee of the Chinese Association of Rehabilitation Medicine, and director of the Institute of Cardiovascular Diseases, Peking University People's Hospital. Prof. Hu was the first person in China to successfully cure tachyarrhythmia with radiofrequency ablation, and he he made great contributions to the treatment of acute myocardial infarction. He also launched a “Chest Pain Center” and has been actively promoting the integration of evidence-based medicine and clinical practice. With a focus on clinical epidemiological research, Prof. Hu organized the largest epidemiological cohort study on atrial fibrillation in China. Prof. Hu has published more than 500 articles in domestic and international scholarly journals and edited over 60 books. He has also won 6 Second Prizes of the State Science and Technology Progress Award.



Cardiovascular and Cerebrovascular Section


Associate Editors-in-Chief

Yuxin Fan, M.D., Ph.D., FACMG, Texas Children's Hospital, Baylor College of Medicine, Houston, United States

Dr. Yuxin Fan is Medical Director of John Welsh Cardiovascular Diagnostic Laboratory, Assistant Professor of Pathology & Immunology and Pediatrics, Baylor College of Medicine. His clinical interests mainly involve in the development and implantation of molecular genetic diagnosis of inherited human diseases, especially cardiovascular disorders using Sanger sequencing, next generation sequencing (NGS) and array-based comparative genomic hybridization (aCGH). I am also interested in developing viral testing for the molecular diagnosis of myocarditis and for the molecular monitoring of heart transplant rejection. His research interests have been focused on cardiovascular genetics, especially on the genetic screening for new genes related to cardiovascular disease and on the understating of mechanisms behind inherited cardiomyopathy using cellular and knock-in/out animal models.


Dongfeng Gu, M.D., Ph.D., Southern University of Science and Technology, Shenzhen, China 

Dongfeng Gu is Academician of Chinese Academy of Sciences, Acting Vice President and Chair Professor of Southern University of Science and Technology (SUSTech) . Formerly as the Deputy Director of National Center for Cardiovascular Diseases, and the Vice President of Fuwai Hospital, Chinese Academy of Medical Sciences, he currently serves as the Vice President for both Chinese Preventive Medicine Association and China International Exchange and Promotive Association for Medical and Health Care. He is an expert for the World Health Organization prevention and control of cardiovascular and chronic diseases, a member of the expert consultation panel of Healthy China initiative, a committee member of Medical Science Department of Academic Advisory Committee of Chinese Academy of Medical Sciences, and the Deputy Director of Pharmaceutical Sciences, Health and Environment, Biomedical Engineering and Information Science Department of Academic Advisory Committee of Chinese Academy of Medical Sciences. Dr. Gu has been long devoted to and specialized in preventive cardiology, epidemiology, and medical genetics.


Editorial Board

  Li Su, Ph.D., University of Cambridge, Cambridge, United Kingdom

 Xiao Tan, Ph.D., Uppsala University, Uppsala, Sweden

 Kai Hu, M.D., University of Würzburg, Würzburg, Germany

  Rongchong Huang, M.D., Ph.D., Beijing Friendship Hospital, Captial Medical University, Beijing, China

 Gianfranco Parati, M.D., University of Milan-Bicocca and San Luca Hospital, Milan, Italy

  Xiantao Song, M.D., Ph.D., Beijing Anzhen Hospital, Capital Medical University, Beijing, China

  Hao Xue, M.D., Ph.D., General Hospital of the People's Liberation Army, Beijing, China

 Guoping Peng, M.D., Ph.D., The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

 Fred C Lam, M.D., Ph.D., FRCSC, McMaster University Faculty of Health Sciences, Hamilton, Canada



Cancer Section

Associate Editors-in-Chief

Nianzeng Xing, M.D., Ph.D., Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China 

Professor Nianzeng Xing is the head of the Urology Department, Cancer Hospital of the Chinese Academy of Medical Sciences, National Cancer Center; he is also a member of the CPPCC National Committee. He has a doctorate from the Beijing Medical University and a postdoctoral degree from the Mayo Medical Center in the United States. Prof. Xing is both a national candidate of the “Baiqianwan Talent Program” and at national level one of the “Young and Middle-aged Experts with Outstanding Contributions”. He currently serves multiple important academic positions, including being the vice president and director-general of the Urology Branch of the Chinese Medical Doctor Association, a member of the Urology Branch of the Chinese Medical Association, etc.
Having worked at the front line of clinical practice for a long time, Prof. Xing is famous for his rich clinical experience and outstanding surgical skills. He is good at the diagnosis and treatment of urinary tract tumors and is especially experienced in minimally invasive urinary surgery and comprehensive treatment. Prof. Xing has not only held consultations for surgeries at nearly 100 local hospitals but he has also performed dozens of surgical demonstrations in academic conferences at home and abroad. His other achievements include undertaking several important national and Beijing municipal projects. Prof. Xing has published nearly 300 professional papers in renowned domestic and international journals, of which more than 70 have been included in SCI. He has also won multiple science and technology progress awards.


Jiafu Ji, M.D., Ph.D., Beijing Cancer Hospital, Beijing, China 

Professor Jiafu Ji has been engaged in clinical practice and scientific research on gastric cancer surgery for 36 years. He is not only the founder and promoter of the standardization of gastric cancer surgery and perioperative treatment in China but also the first Chinese expert to serve as the chairman of the International Gastric Cancer Association (IGCA). Prof. Ji’s current roles include being the director of the Beijing Cancer Hospital (Peking University School of Clinical Oncology), director of the Beijing Institute for Cancer Research, director of the Key Laboratory of Malignant Tumor Pathogenesis and Translation of the Ministry of Education, and director of the Peking University Cancer Research Center. Prof. Ji’s titles include professor, chief physician, doctoral supervisor, and expert who receives the state council special allowance. Prof. Ji also serves as the vice chairman of the Chinese Anti-Cancer Association, chairman of the Hospital Management Branch of the Chinese Anti-Cancer Association, vice chairman of the China International Exchange and Promotive Association for Medical and Health Care, standing director of the Chinese Medical Association, member of the Standing Committee and secretary-general of the Branch of Surgery of the Chinese Medical Association, as well as chairman of the Oncology Surgeon Committee of the Chinese Medical Doctor Association. In addition, Prof. Ji also serves as a member of the American College of Surgeons (FACS) and the Standing Committee of the Asian Surgical Association (ASA), and he is a Fellow of the Royal Colleges of Surgeons (FRCS).


Lei Zheng, M.D., Ph.D., John Hopkins University School of Medicine, Baltimore, United States 

Dr. Lei Zheng is an oncologist in Baltimore, caring for patients with conditions such as pancreatic cancer and gastrointestinal cancers. Regarded as one of the world’s top clinical specialists in pancreatic cancer, Dr. Zheng receives referrals from around the world.  He is an internationally recognized expert in the tumor microenvironment of pancreatic cancer and in mouse models of pancreatic cancer and preclinical studies of combinational immunotherapies. Dr. Zheng serves as co-director of the Pancreatic Cancer Precision Medicine Center of Excellence Program at the Johns Hopkins School of Medicine.

 

Editorial Board


 
Connie Lee Batlevi
, M.D., Ph.D., Memorial Sloan Kettering Cancer Center, New York, United States

 Charles Nicholas Catton, M.D., Princess Margaret Hospital, Toronto, Canada

 Christos Dervenis, M.D., FRCS, University of Cyprus, Athens, Greece

 Kaihua Lu, M.D., Ph.D., Jiangsu Province Hospital, Nanjing, China

 Xuanlu Melody Qu, M.D., MPH, London Health Science Centre, London, Canada

 Ningning Lu, M.D., MPH, Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China

 Qi Zhang, M.D., Ph.D., The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

 Kai Li, M.D., Ph.D., China Medical University, Shenyang, China

 Junling Zhuang, M.D., Ph.D., Peking Union Medical College Hospital, Beijing, China

 Xiao Li, M.D., Ph.D., Peking University People's Hospital, Beijing, China

  Zhihong Zhang, M.D., Ph.D., Providence Regional Medical Center, Everett, United States



Respiratory Section

Associate Editors-in-Chief

Lixin Xie, M.D., Ph.D., General Hospital of the People's Liberation Army, Beijing, China 

Professor Lixin Xie is the director of the Department of Respiratory and Critical Care Medicine, Chinese PLA General Hospital, as well as a chief physician, professor, and doctoral supervisor. Prof. Xie is experienced in the diagnosis and treatment of critical diseases of the respiratory system, and his main focus is on the basic and clinical research of critical diseases of the respiratory system, severe infections, rejection and infection after transplantation, multiple organ dysfunction, and respiratory rehabilitation. He has achieved innovative results in the research of lung injury and tissue repair, respiratory support, early diagnosis of infections, imbalance of infection and immunity, and respiratory rehabilitation. Prof. Xie is currently a national committee member of the Respiratory Disease Branch of the Chinese Medical Association and the leader of the Respiratory Therapy Group, as well as a consultant of the Critical Care Group. In addition, Prof. Xie serves as the deputy editor-in-chief of the Chronic Diseases and Translational journal and the International Journal of Respiration. His articles have been included in more than 20 SCI journals, including the American Journal of Respiratory & Critical Care Medicine, Crit Care Med, and BMJ Open. Prof. Xie is a standing editor/editor/guest reviewer of the National Medical Journal of China (Chinese Version), Chinese Journal of Internal Medicine, Chinese Journal of Tuberculosis and Respiratory Diseases, and International Journal of Respiration. He is also an expert reviewer of the science and technology awards of the Ministry of Science and Technology, Health and Family Planning Commission, Ministry of Education, Beijing Municipality, and PLA; a peer-review expert of the National Natural Science Foundation of China; and a medical expert of the Chinese Medical Association.


Joe Y. Chang, M.D., Ph.D., FASTRO, The University of Texas MD Anderson Cancer Center, Houston, United States 

Joe Y. Chang (MD, PhD, FASTRO) is a tenured Professor, Director of Stereotactic Ablative Radiotherapy (SABR), MD Anderson Cancer Center. He is the Fellow of American Society of Radiation Oncology and received the award of “The Best Doctors in America”.  He is the current chair for American Radium Society/American College of Radiology (ACR) Thoracic Appropriateness Use Criteria Committee, chair of thoracic subcommittee of international Particle Therapy Co-Operative Group (PTCOG), NCCN Thoracic Guidelines Voting Committee Member; He served as a Section Chief of MD Anderson Thoracic Radiation Oncology, senior associate editor for International Journal of Radiation Oncology Biology Physics (Red Journal) and is an editorial board members for several international medical journals.   He was the president and Chair of Board of Sino-American Network of Therapeutic Radiology and Oncology (SANTRO).  He is an international renowned expert in radiotherapy and one of the pioneers in the field of proton therapy, stereotactic radiotherapy and immunotherapy in lung cancer.  He is PI or Co-PI for many institutional, national and international clinical trials in lung cancer. He published more than 250 peer-reviewed SCI articles in the top oncology journals including Lancet Oncology, Nature Review Clinical Oncology, JAMA Oncology, JCO, JAMA Surgery, JAMA Network Open, Clinical Cancer Research, Cancer, Journal of Thoracic Oncology, Intentional Journal of Radiation Oncology Biology Physics and etc. He edited 5 books and published 24 book chapters related to image-guided radiation therapy, stereotactic ablative radiation therapy, intensity-modulated radiotherapy, proton therapy and combined immunotherapy with radiotherapy.

 

Editorial Board

 Yin Chen, Ph.D., University of Arizona, Tucson, United States

 Qutayba Hamid, M.D., Ph.D., McGill University, Montreal, Canada

 Bo Hang, M.D., Ph.D., Lawrence Berkeley National Laboratory, Berkeley, United States

 Gang Liu, M.D., Ph.D., University of Alabama at Birmingham, Birmingham, United States

 Xiangde Liu, M.D., Ph.D., University of Nebraska Medical Center, Omaha, United States

 Yongzheng Wu, M.D., Ph.D., Institut Pasteur, Paris, France

 Ting Yang, M.D., Ph.D., China-Japan Friendship Hospital, Beijing, China

 Shugeng Gao, M.D., Ph.D., Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China

 Dianhua Jiang, M.D., Ph.D., Cedars Sinai Medical Center, Los Angeles, United States

 Chun Chang, M.D., Ph.D., Peking University Third Hospital, Beijing, China

 Mengshu Cao, M.D., Ph.D., Nanjing Drum Tower Hospital, Nanjing, China

 Lei Gao, M.D., Ph.D., Institute of Medical Biology, Chinese Academy of Medical Sciences, Beijing, China

 Chaosheng Deng, M.D., Ph.D., Fujian Medical University, Fuzhou, China



Endocrine Section

Associate Editors-in-Chief

Lixin Guo, M.D., Ph.D., Beijing Hospital, Beijing, China 

Professor Lixin Guo is the director of the Department of Endocrinology, National Center for Geriatrics, Beijing Hospital. He is also a member of the Chronic Disease Expert Committee of the National Health Commission, chairman-designate of the Diabetes Branch of the Chinese Medical Association, and vice-chairman of the Endocrinology and Metabolism Branch of the Chinese Medical Doctor Association. His main topics of interest include the pathogenesis and interventions of diabetic vascular disease, diabetes-related diseases, and endocrine and metabolic diseases in the elderly. Prof. Guo has undertaken and participated in several major national projects and provincial and ministerial research projects, including the “Tenth Five-year”, “Eleventh Five-year”, and “Twelfth Five-year” Key Projects of the Ministry of Science and Technology, National Key Technology R&D Projects, National Key Technology R&D Program of the Ministry of Science and Technology, National Natural Science Foundation Projects, Key Projects of the Beijing Municipal Science and Technology Commission, Beijing Major Scientific Research Projects, Beijing Natural Science Foundation Projects, National Health Care Commission Projects, Chinese Medical Association Projects, Beijing Medical Association Projects, Industry Funds, etc. He has not only published over 210 papers, 60 of which have been included in SCI journals, but also edited or co-edited 25 monographs and teaching materials on endocrinology.


Yiming Mu, M.D., Ph.D., General Hospital of the People's Liberation Army, Beijing, China 

Professor Yiming Mu is the director of the Department of Endocrinology, Chinese PLA General Hospital, chief physician, professor, and doctoral supervisor of the Chinese PLA General hospital, as well as professor and doctoral supervisor of the School of Medicine, Tsinghua University and School of Medicine, Nankai University. Prof. Mu is experienced in the treatment of endocrine and metabolic diseases, such as diabetes and diseases of the adrenal glands, pituitary gland, and gonads. He currently serves as the chairman of the Tenth Committee of the Endocrinology Branch of the Chinese Medical Association, chairman-designate of the Endocrinology and Metabolism Physician Branch of the Chinese Medical Doctor Association, chairman of the Endocrinology Committee of the Chinese PLA Medical Association, and chairman of the Endocrinology Branch of the Beijing Medical Association. Prof. Xie has won a Military Science and Technology Progress Award as well as two Second Prizes of the Military Medical Achievement Award. He has also undertaken three National Major Science and Technology R&D Projects and five National Natural Science Foundation Projects. Prof. Mu has not only published over 200 SCI papers and about 500 papers in domestic core journals but also edited 10 monographs on endocrinology and diabetes. His other contributions include the supervision of more than 70 doctoral, masters, and post-doctoral students. Prof. Mu has dedicated himself to basic and clinical research on stem cell treatment for diabetes and its complications in the past 15 years.

 

Editorial Board

 Tianpei Hong, M.D., Ph.D., Peking University Third Hospital, Beijing, China

 Tianru Jin, M.D., Ph.D., University of Toronto, Ontario, Canada

 Wenjun Shen, Ph.D., Stanford University School of Medicine, Stanford, United States

 Zhihong Yang, Ph.D., Indiana University School of Medicine, Indianapolis, United States

 Quan Zhang, Ph.D., Oxford University, Oxford, United Kingdom

 Ying Gao, M.D., Ph.D., Peking University First Hospital, Beijing, China

 Yongfeng Song, Ph.D., Shandong Provincal Hospital, Jinan, China

 Rui Wei, M.D., Ph.D., Peking University Third Hospital, Beijing, China

 Ningjian Wang, M.D., Ph.D., Shanghai Ninth Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China



Gastroenterology Section

Associate Editors-in-Chief

Shutian Zhang, M.D., Ph.D., Beijing Friendship Hospital, Captial Medical University, Beijing, China 

Professor Shutian Zhang is the director of the Beijing Friendship Hospital, Capital Medical University, secretary-general of the National Collaborative Research and Innovation Alliance of Clinical Medicine, director of the National Clinical Research Center for Digestive Diseases, chairman of the Digestive Endoscopy Branch of the Chinese Medical Association, chairman of the Digestive Physician Branch of the Chinese Medical Association, and member of the Scientific Committee of the World Endoscopy Organization (WEO). His focus in clinical practice is on diagnosis and treatment using digestive endoscopy (minimally invasive), including endoscopic resection of early cancer, stent placement for advanced cancer, ligation and sclerotherapy for bleeding in liver cirrhosis, endoscopic hemostasis for bleeding ulcers, endoscopic removal of gallstones, and endoscopic treatment of pancreatitis. His focus in scientific research is the molecular mechanisms, intervention measures, and early diagnosis and treatment of precancerous diseases of the digestive system. Prof. Zhang has so far published more than 130 papers in international and domestic academic conferences and journals.


Zhenning Wang, M.D., Ph.D., The First Hospital of China Medical University, Shenyang, China 

Professor Zhenning Wang is a standing member of the Party Committee and vice president of the China Medical University, as well as director, level-II professor, and doctoral supervisor of the Department of Gastrointestinal Cancer Surgery, First Affiliated Hospital of China Medical University. He is an expert with outstanding contributions to the National Health and Family Planning Commission, and a science and technology leader of the Innovative Talent Promotion Plan of the Ministry of Science and Technology. He also receives special government allowances from the State Council. Prof. Wang has hosted a special project of precision medicine of the National Major Science and Technology R&D Projects, a special research project of the 973 Program, 5 projects of the National Natural Science Foundation, a project of the Program for New Century Excellent Talents in University of Ministry of Education, and 21 other provincial and ministerial projects. His publications include 217 SCI papers, 131 of which he is either the first author or the corresponding author. Prof. Wang has also won 1 Second Prize of the State Science and Technology Progress Award, as well as 3 First Prizes, 4 Second Prizes, and 3 Third Prizes of the Provincial and Ministerial Science and Technology Progress Award.

 

Editorial Board

 Jaffer A. Ajani, M.D., The University of Texas MD Anderson Cancer Center, Houston, United States

 Chong Choon Seng, MBBS, MRCS, Mmed, FRCS, National University Hospital, Singapore, Singapore

 Peng Li, M.D., Ph.D., Beijing Friendship Hospital, Captial Medical University, Beijing, China

 Guoxiang Cai, M.D., Ph.D., Fudan University Shanghai Cancer Center, Shanghai, China

 Haizeng Zhang, M.D., Ph.D., Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China

 Jun Yu, M.D., Ph.D., Johns Hopkins University School of Medicine, Baltimore, United States



Nephrology Section

Associate Editors-in-Chief

Peter Hammerer, M.D., Städtischen Klinikum Braunschweig/Municipal Clinic Braunschweig, Braunschweig, Germany 

Prof. Dr. med. Peter Hammerer is leading the Urology Clinic of the Academic Hospital in Braunschweig since 2003, which is one of the largest Hospitals in Germany. Prof. Dr. Hammerer is an internationally renowned expert in the field of diagnosis and treatment of urological cancers. He is in the Board of Directors of the German Cancer Group (Association of Urological Oncology (AUO)), leading the Prostate group and member of the Board of the Societe International Urology (SIU) and co-editor of numerous scientific journals. He was in the BOD of the European School of Urology (ESU) and board member and is Past-President of the EAU Section of Oncology in Urology (ESOU). He is also Past-President of the Northern German Urology Assosciation. In 2019 he was elected as chairman of the World Uro Oncology Federation (WUOF). The purpose of the WUOF is to provide a formal liason between the national urooncological working groups on a global level. His main topics include: Urological oncology,  prostate cancer research, diagnosis and therapy, Nerve-sparing radical prostatectomy and Men's health.


Wenge Li, M.D., Ph.D., China-Japan Friendship Hospital, Beijing, China 

Professor Wenge Li is the director of the Nephrology Department of the China-Japan Friendship Hospital of the Ministry of Health, and at the same time, he also serves as the chairman of the Urology and Blood Purification Committee of the Chinese Medical Education Association, vice chairman of the Nephrology Branch of the Chinese Medical Association, and member of the Standing Committee of the Nephrology Branch of the Chinese Medical Doctor Association. His focus is on the diagnosis and treatment of chronic nephritis, diabetic nephropathy and hypertension-induced renal damage, blood purification, etc. Prof. Li has published over 130 papers, lecture notes, reviews, summaries, and other articles.


Xueqing Yu, M.D., Ph.D., Guangdong Provincial People's Hospital, Guangzhou, China 

Professor Xueqing Yu is the director of Guangdong General Hospital (Guangdong Academy of Medical Sciences) and deputy secretary of the Party Committee of the hospital. He also serves as the chairman of the Chinese Society of Nephrology and deputy editor-in-chief of the journal of Chronic Disease and Translational Medicine. His other titles include the president-elect of the International Society of Peritoneal Dialysis, executive council member of the Asian Pacific Society of Nephrology, chairman of the Asian Renal Alliance, and editorial board member of the American Journal of Nephrology. Prof. Yu has so far undertaken 44 scientific research funds of different levels and published 443 scientific papers. Among them, 181 papers have been included in SCI journals, 91 of which he is either the first or the corresponding author. He has also published 17 monographs, 8 of which he is the editor-in-chief. Prof. Yu has also established an internationally leading peritoneal dialysis center. Since the patients survival rates of this center are at advanced levels in the world, it is complimented as the “Guangzhou Model”. In addition, “The Lancet”, a world-renowned journal, has called Prof. Yu “the heart of the development of Chinese nephrology”. He has also introduced to the world “Implementing a successful peritoneal dialysis program in a developing Country” in The Lancet.

 

Editorial Board

 Qi Cao, Ph.D., Westmead Institute for Medical Research, The University of Sydney, Sydney, Australia

 Lihua Dong, Ph.D., University Hospital of Copenhagen Rigshospitalet, Copenhagen, Denmark

 Ji Li, Ph.D., University of South Florida, Tampa Bay, United States

 Song Rong, M.D., Hannover Medical School, Hannover, Germany

 Jian Yao, M.D., Ph.D., University of Yamanashi, Yamanashi, Japan

 Hong Jiang, M.D., Ph.D., The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

 Wei Chen, M.D., Ph.D., The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China



Basic Medical Science and Life Science Section

Associate Editor-in-Chief

Minghui Zou, M.D., Ph.D., Georgia State University, Center for Molecular and Translational Medicine, Atlanta, United States 

Ming-Hui Zou, M.D. Ph.D. is the eminent scholar in Georgia Research Alliance in Georgia, USA. Dr. Zou is the founding director, the Center of Molecular and Translational Medicine, and the Associate Vice President for Research, Georgia State University. Before he joined the Georgia State University, Dr. Zou was the George Lynn Cross Professor, Warren Endowed Chair in Diabetes Research, and Travis endowed Chair in Endocrinology in the University of Oklahoma Health Science Center, the Chief of Section of Molecular Medicine, and Vice Chair for Research in the Department of Medicine from 2005-2015. Dr. Zou has been instrumental in examining the role of nitric oxide and oxidative stress in the regulation of blood flow and vascular function. He performed elegant, state of the art, studies to show that the selective modification of two key proteins, prostacyclin synthase and endothelial nitric oxide synthase, is critical in the dysregulation of vessel function from nitric oxide and superoxide.

 

Editorial Board

 Igor Buzaev, M.D., Ph.D., GBUZ Republic Heart Centre, Ufa, Russia

 Yong Du, Ph.D., The Royal Marsden Hospital/GenesisCare, London, United Kingdom

 Zigang Ge, M.D., Ph.D., Peking University, Beijing, China

 Qiushui He, M.D., Ph.D., University of Turku, Turku, Finland

 Joseph T.F. Lau, Ph.D., The Chinese University of Hong Kong, Hong Kong, China

 Myeong Soo Lee, Ph.D., The Korea Institute of Oriental Medicine, Daejeon, South Korea

 Li Li, M.D., National Jewish Health/ University of Colorado Denver, Denver, United States

 Junqi Qian, M.D., Virginia Urology Pathology Laboratory, Richmond, United States

 Suimin Qiu, M.D., Ph.D., The University of Texas Medical Branch at Galveston, Galveston, United States

 Jianyu Rao, M.D., University of California, Los Angeles, United States

 Jiangning Song, Ph.D., Monash University, Biomedicine Discovery Institute, Melbourne, Australia

 Jing Sun, Ph.D., Griffith University, Brisbane, Australia

 Wei Wang, M.D., School of Medicine New York University, New York, United States

 Lin Zhang, Ph.D., The Chinese University of Hong Kong, Hong Kong, China

 Xiaofei Zhang, M.D., Ph.D., Beijing Tsinghua Changgung Hospital, Beijing, China

 Xiangfeng Lu, M.D., Ph.D., National Center for Cardiovascular Diseases, Beijing, China

 Yubin Zhou, M.D., Ph.D., College of Medicine, Texas A&M University, Houston, United States

 Wei Wang, M.D., Ph.D., FFPH, Edith Cowan University, Perth, Australia


Managing Director

Yi Cui, Chinese Medical Association Publishing House

Yi Cui obtained his bachelor degree and master degree in Peking University Health Science Center, and has more than 12 years of experience in STM Journal publishing. He is also the deputy director of International Exchange and Cooperation Working Committee of China Editology Society of Science Periodicals (CESSP) and Member of Journal Publishing Professional Committee of China Anti-Cancer Association.



Publisher

Wanshu ZhangJohn Wiley & Sons, Inc.

Wanshu Zhang obtained her B.Sc. from the University of Science and Technology Beijing (USTB). She conducted her Ph.D. study at Peking University based on a cooperation project with USTB. After her post-doctoral research at Eindhoven University of Technology, she joined Wiley as a journal publishing manager. At present, she is Associate Publisher, Health Sciences and oversees a journal portfolio and strategic publishing project. Her responsibility also includes managing partnership journal business with Chinese societies.


Publishing Assistant

Siyue Xiao, John Wiley & Sons, Inc.

Siyue Xiao received her MSc from University of Warwick, Coventry, UK, with major in e-Business Management, and further acquired a Postgraduate Diploma in Asian Arts from SOAS, University of London, London, UK, in pursuing her interests in art history. She has worked in a literature agency handling foreign book rights for 2.5 years before she joined Wiley as a Journal Publishing Assistant in Health Sciences team.